Director/PDMR Shareholding

RNS Number : 3356W
Dr. Martens PLC
14 April 2023
 

Dr. Martens plc (the 'Company')

Director/PDMR Shareholding

Notification of Transactions by Directors/Persons Discharging Managerial Responsibility

The Company announces that it was notified on 13 April 2023 of the following transactions in the Company's Ordinary 1p shares undertaken by directors / persons discharging managerial responsibility ('PDMRs') under the Company's Share Incentive Plan ('SIP').

The SIP is an HMRC approved, all-employee scheme under which participating employees are able to purchase shares in the Company from monthly salary ('Partnership Shares') and receive allocations of free 'Matching Shares', awarded at a rate of one Matching Share for every one Partnership Share purchased by a participating employee, from the Company.

 

On 11 April 2023, the following directors / PDMRs acquired Partnership Shares as a result of their participation in the SIP at a price of 142 pence per share and were granted allocations of Matching Shares (for no consideration) in the quantities set out   in the table below:

 

Director / PDMR

Number of Partnership Shares purchased

Number of
Matching Shares awarded

Kenny Wilson

105

105

Jon Mortimore

105

105


The relevant notifications set out below are provided in accordance with the requirements of Article 19 of the UK Market Abuse Regulation.

 

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Kenny Wilson

2

Reason for the notification

a)

Position/status

PDMR (Chief Executive Officer)

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Dr. Martens plc

b)

LEI

213800QPT8YM6NQZPH28

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of GBP 0.01


ISIN: GB00BL6NGV24

b)

Nature of the transaction

1. Purchase of Partnership Shares under the SIP

2. Award of Matching Shares under the SIP

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

1.

142p

105

2.

Nil

105

d)

Aggregated information

 

-

Aggregated volume

-

Price

 

 

-

Aggregated volume

-

Price

 

 

1.

Partnership shares


105


142p

 

2.

Matching shares


105


Nil

e)

Date of the transaction

11 April 2023

f)

Place of the transaction

1. London Stock Exchange (XLON)

2. Outside of a trading venue

 

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Jon Mortimore

2

Reason for the notification

a)

Position/status

PDMR (Chief Financial Officer)

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Dr. Martens plc

b)

LEI

213800QPT8YM6NQZPH28

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of GBP 0.01

 

ISIN: GB00BL6NGV24

b)

Nature of the transaction

1. Purchase of Partnership Shares under the SIP

2. Award of Matching Shares under the SIP

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

1.

142p

105

2.

Nil

105

d)

Aggregated information

 

-

Aggregated volume

-

Price

 

 

-

Aggregated volume

-

Price

 

 

1.

Partnership shares


105


142p

 

2.

Matching shares


105


Nil

e)

Date of the transaction

11 April 2023

f)

Place of the transaction

1. London Stock Exchange (XLON)

2. Outside of a trading venue

 

For further information please contact:

 

Rebecca Flaherty

Company Secretarial Assistant

+447570 309775

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHUSSWRORUSAAR

Companies

Dr. Martens (DOCS)
UK 100

Latest directors dealings